MBMayra de Souza El Beck

Mayra de Souza El Beck

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mayra de Souza El Beck has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patients with genital ambiguity referred without a sex definition: the relationship between clinical picture and defined sex of rearing

    by Henrique C. Santos, Beatriz A. Barros, Mayra S. El-Beck, Marcio L. Miranda, Mara S. Guaragna, Helena Fabbri-Scallet, Taís N. Mazzola, Tarsis P. Vieira, Maricilda P. Mello, Antonia P. Marques-De-Faria, et al.

  • Open Access

    Ambulatório de Gênero e Sexualidades (AmbGen/ HC/ UNICAMP)

    by Rafael Gobbo, Mayra De Souza El Beck, Kamila Baruque Bignotto, Daniel Nigro Lopes, Nathália Ajudarte Lopes, Karine Schlúter, Octavio De O. Santos Neto, Ana Helena Elias Alvim, Flávia Flávia Cavaletti, Eduardo Belanga, et al.

    0 Ambulatério de Género e Sexualidades (AmbGen) do Hospital das Clinicas da Universidade Estadual de Campinas é um dos poucos dispositivos publicos que acolhem população da infancia e adolescência com variabilidade de género. A psiquiatria e psicologia investigam transtornos mentais, desencadeadores do sofrimento psfquico, disforias relacionados à incongruência de géneto e, no caso de criancas e adolescentes, acolhem as familias buscando compreensao da dinamica familiar, esclarecimento de dúvidas e estigmas. A intervenção hormonal na adolescéncia é possivel em dois momentos: no inicio da puberdade, através de terapia medicamentosa visando blogueio puberal, e hormonização cruzada. A adequação corporal & identidade de género da pessoa trans, através da hormonização, é desejada pela maior parte dos adultos atendidos. A arteterapia realiza atendimentos nos quais busca fornecer padrdes adequados à questdes relevantes, utilizando- se de modalidades expressivas e vivéncias de processos criativos, uma maneira terapéutica diferenciada que propicia um ambiente acolhedor por um viés artistico. Caracteristicas de gênero e voz são muito abrangentes. Sendo assim, a terapia fonoaudiológica a pessoas trans nao se restringe apenas a produção vocal, mas também se relaciona a outros aspectos da comunicagdo e do discurso.

  • Open Access

    Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?

    by Mariana Zorron1, Fernando Augusto Lima Marson2, André Moreno Morcillo1, Aline Cristina Gonçalves1, Mayra de Souza El Beck1, José Dirceu Ribeiro1, Antonio Fernando Ribeiro1

    Objective: To determine whether abnormal continuous glucose monitoring (CGM) readings (hypoglycemia/hyperglycemia) can predict the onset of cystic fibrosis-related diabetes (CFRD) and/or clinical impairment (decline in BMI and/or FEV1) in pediatric patients with cystic fibrosis (CF). Methods: This was a longitudinal prospective cohort study involving CF patients without diabetes at baseline. The mean follow-up period was 3.1 years. The patients underwent 3-day CGM, performed oral glucose tolerance test (OGTT), and had FEV1 and BMI determined at baseline. OGTT, FEV1, and BMI were reassessed at the end of the follow-up period. Results: Thirty-nine CF patients (10-19 years of age) had valid CGM readings at baseline, and 34 completed the follow-up period (mean = 3.1 ± 0.5 years). None of the study variables predicted progression to CFRD or were associated with hypoglycemic events. CGM could detect glucose abnormalities not revealed by OGTT. Patients with glucose levels = 140 mg/dL, as compared with those with lower levels, on CGM showed lower BMI values and z-scores at baseline-17.30 ± 3.91 kg/m2 vs. 19.42 ± 2.07 kg/m2; p = 0.043; and -1.55 ± 1.68 vs. -0.17 ± 0.88; p = 0.02, respectively-and at the end of follow-up-17.88 ± 3.63 kg/m2 vs. 19.95 ± 2.56 kg/m2; p = 0.039; and -1.65 ± 1.55 vs. -0.42 ± 1.08; p = 0.039. When comparing patients with and without CFRD, the former were found to have worse FEV1 (in % of predicted)-22.67 ± 5.03 vs. 59.58 ± 28.92; p = 0.041-and a greater decline in FEV1 (-36.00 ± 23.52 vs. -8.13 ± 17.18; p = 0.041) at the end of follow-up. Conclusions: CGM was able to identify glucose abnormalities not detected by OGTT that were related to early-stage decreases in BMI. CGM was ineffective in predicting the onset of diabetes in this CF population. Different diagnostic criteria for diabetes may be required for individuals with CF.


  • Open Access

    Why pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service

    by Mayra de Souza El Beck, Carlos W. Germano, Beatriz A. Barros, Juliana G.R. Andrade, Guilherme Guaragna‐Filho, Georgette B. Paula, Márcio L. Miranda, Mara S. Guaragna, Helena Fabbri‐Scallet, Tais N. Mazzola, et al.

  • Open Access

    Why pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service

    by Mayra de Souza El Beck, Carlos W. Germano, Beatriz A. Barros, Juliana G.R. Andrade, Guilherme Guaragna-Filho, Georgette B. Paula, Márcio L. Miranda, Mara S. Guaragna, Helena Fabbri-Scallet, Tais N. Mazzola, et al.